PHASE II TRIAL OF TESMILIFENE PLUS MITOXANTRONE AND PREDNISONE FOR HORMONE REFRACTORY PROSTATE CANCER: HIGH SUBJECTIVE AND OBJECTIVE RESPONSE IN PATIENTS WITH SYMPTOMATIC METASTASES-Reference-Cited by-同舟云学术

PHASE II TRIAL OF TESMILIFENE PLUS MITOXANTRONE AND PREDNISONE FOR HORMONE REFRACTORY PROSTATE CANCER: HIGH SUBJECTIVE AND OBJECTIVE RESPONSE IN PATIENTS WITH SYMPTOMATIC METASTASES

Published:2005-11 Issue:5 Volume:174 Page:1808-1813
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

RAGHAVAN D.¹,BRANDES L.J.¹,KLAPP K.¹,SNYDER T.¹,STYLES E.¹,TSAO-WEI D.¹,LIESKOVSKY G.¹,QUINN D.I.¹,RAMSEY E.W.¹

Affiliation:

1. From the University of Southern California, Los Angeles, California, University of Manitoba, Winnipeg, Manitoba, Canada, and Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Chemotherapy for hormone-refractory prostate cancer: beauty is in the eye of the beholder.;Beer;Prostate,2000

2. Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer;Osborne;Cancer Treat Rep,1983

3. Management of hormone-resistant prostate cancer: an Australian trial;Raghavan;Semin Oncol, suppl.,1996

4. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points;Tannock;J Clin Oncol,1996

5. Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia Group B 9182 study;Kantoff;J Clin Oncol,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Effects of Nobiletin and Sorafenib Combination on Metastatic Prostate Cancer Cells;Nutrition and Cancer;2019-04-30

2. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death;Biochemical Pharmacology;2017-11

3. Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties;Current Medicinal Chemistry;2015-10-19

4. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier;Journal of Neurochemistry;2015-07-23

5. Castrate Resistant Prostate Cancer: Systemic Chemotherapy and a System Problem;Urological Oncology;2014-11-04